Oscar Health Inc.

03/02/2026 | Press release | Distributed by Public on 03/02/2026 05:42

Regulation FD Disclosure (Form 8-K)

Item 7.01. Regulation FD Disclosure.
Oscar Health, Inc. (the "Company") will participate in the 2026 Raymond James Institutional Investors Conference (the "Conference") on March 2, 2026. At the Conference, the Company will reaffirm the full year 2026 guidance that it provided in its financial results press release for the fourth quarter and full-year 2025, dated February 10, 2026.
This information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in any such filing.
Oscar Health Inc. published this content on March 02, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on March 02, 2026 at 11:42 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]